Stock Screener App

無料 - Play StoreApp Store

インストールインストール

Dow:

Nasdaq:

S&P 500:

APMD

$16.181.34%-0.22

Apnimed, Inc. Common Stock (APMD)

Date: O: H: L: C: Vol:

Apnimed, Inc. Common Stock (APMD) 最新ニュース

Obstructive Sleep Apnea Clinical Trial and Competitive Landscape Expands as 18+ Leading Companies Accelerate Drug Development | DelveInsight - GlobeNewswire Inc.

Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Apnimed gives 19 new hires the right to buy 481,300 shares - Stock Titan

Apnimed Reports FDA Acceptance of Oxnimbi NDA, Q2 2026 Results and Corporate Update | APMD Stock News - Quiver Quantitative

Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Apnimed (APMD) CEO Lind logs large stock option reclassification and vesting terms - Stock Titan

Apnimed, Inc. (APMD) Company Information - Simply Wall Street

Apnimed raises USD 192m in IPO ahead of Q1 2027 sleep apnea drug decision - AllSci

Sleep drug developer Apnimed rises on trading debut - Seeking Alpha

Upcoming and recent IPOs – IPOs calendar - Yahoo Finance UK

Apnimed (APMD) Stock Price, News & Analysis - Stock Titan

Apnimed Announces Pricing of Upsized Initial Public Offering - PR Newswire

Apnimed prices IPO at $16 per share, raising $192 million - Investing.com

Apnimed closes upsized IPO, raising $220.8 million - scanx.trade

Apnimed prices IPO at $16 per share, raising $192 million - Investing.com

Pharma M&A Roundup: Oak Hill Bio Combines with RACC, Apnimed Plans $150 Million IPO, CORE Biomedicine Secures $21 Million Series A - Pharmaceutical Executive

Upcoming and recent IPOs – IPOs calendar - Yahoo Finance Australia

Apnimed Seeks IPO For OSA Treatment Commercialization (APMD) - Seeking Alpha

S-1 - SEC.gov

Upcoming & Recent IPO's - IPOs Calendar - Yahoo Finance

Upcoming and recent IPOs – IPOs calendar - Yahoo Finance Australia

APMDに類似

DNA$10.0810.07%

DSGN$10.531.40%